Sponsor:
Eli Lilly and Company
Code:
NCT06586515
Conditions
Pancreatic Ductal Adenocarcinoma
Non-small Cell Lung Cancer
Colorectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3962673
Cetuximab
Gemcitabine
nab-paclitaxel
Oxaliplatin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-02. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2025-04-22.